Tang, L., Li, X., Li, Z., Liu, Z., Lin, M., Zhou, H., . . . Cai, X. (2023). The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: A prospective, phase II trial. BMC.
Chicago Style (17th ed.) CitationTang, Lin-Quan, et al. The Efficacy and Safety of Apatinib Plus Capecitabine in Platinum-refractory Metastatic And/or Recurrent Nasopharyngeal Carcinoma: A Prospective, Phase II Trial. BMC, 2023.
MLA (9th ed.) CitationTang, Lin-Quan, et al. The Efficacy and Safety of Apatinib Plus Capecitabine in Platinum-refractory Metastatic And/or Recurrent Nasopharyngeal Carcinoma: A Prospective, Phase II Trial. BMC, 2023.
Warning: These citations may not always be 100% accurate.